To determine whether this characteristic heightens bleeding risk in patients with renal insufficiency, researchers in Connecticut compared bleeding rates with enoxaparin and UFH in a retrospective ...

Enoxaparin [23] Observe patients with moderate ... In hemodialysis patients or in patients with acute renal failure (CL cr of <15 mL/min or SCr of >6.0 mg/dL), lepirudin should be avoided or ...

The PESI and sPESI scores incorporate parameters such as age, sex, comorbidities (history of cancer, heart failure or chronic lung disease ... the Hestia criteria uniquely includes variables such as ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Most children with ANCA-associated vasculitis had active kidney disease and impaired renal function at diagnosis. Those with normal or minimal kidney impairment had good chance of recovery.

Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...